[
  {
    "ts": null,
    "headline": "Biogen and City Therapeutics to develop RNAi therapy",
    "summary": "Biogen will pay City Therapeutics $46m, which includes $16m upfront and $30m investment for a convertible note.",
    "url": "https://finnhub.io/api/news?id=6c68e5c45080a99900b4d143e8b1dda69a1509d110140e403aa928ad9e819def",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748424265,
      "headline": "Biogen and City Therapeutics to develop RNAi therapy",
      "id": 134742318,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "Biogen will pay City Therapeutics $46m, which includes $16m upfront and $30m investment for a convertible note.",
      "url": "https://finnhub.io/api/news?id=6c68e5c45080a99900b4d143e8b1dda69a1509d110140e403aa928ad9e819def"
    }
  },
  {
    "ts": null,
    "headline": "Biogen Inc. (BIIB) Taps RNAi Therapy in City Therapeutics Deal",
    "summary": "Biogen Inc. (NASDAQ:BIIB)’s recent partnership with City Therapeutics, Inc. to develop RNAi therapies for central nervous system diseases has fueled a 6% rise in its share price over the past month, reflecting renewed investor optimism. This move comes amid a broader rally in the tech sector driven by favorable policy shifts and positive market sentiment, […]",
    "url": "https://finnhub.io/api/news?id=1e7d92db3a9a6deb916832c5a4b060682f0d92a3ed0504842b833e4bd3cc2df2",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748390487,
      "headline": "Biogen Inc. (BIIB) Taps RNAi Therapy in City Therapeutics Deal",
      "id": 134742319,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BIIB",
      "source": "Yahoo",
      "summary": "Biogen Inc. (NASDAQ:BIIB)’s recent partnership with City Therapeutics, Inc. to develop RNAi therapies for central nervous system diseases has fueled a 6% rise in its share price over the past month, reflecting renewed investor optimism. This move comes amid a broader rally in the tech sector driven by favorable policy shifts and positive market sentiment, […]",
      "url": "https://finnhub.io/api/news?id=1e7d92db3a9a6deb916832c5a4b060682f0d92a3ed0504842b833e4bd3cc2df2"
    }
  }
]